Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-10 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |